Abstract
Preliminary clinical trials reported with adrenal medullary transplants into the CSF for irreductible cancer pain were contradictory. The objective of these phase II study is to confirm the faisability and to evaluate the analgesic activity effects of these approach. The prospective study concern 20 allofrafts for 15 irreductible cancer pain, after failure of oral opioids. All the patients were treated by daily intrathecal (I-Th) morphine administration. The mean follow-up is 92 days (15-365). The analgesic effects are interpreted in function of 3 parameters: pain intensity score (from 0 to 10), activity pattern and complementary narcotic intake. The results were excellent (pain score: 0-1, complete interruption of I-Th morphine) in 5 cases; good (pain score <2, diminution of I-Th morphine) in 2 cases; moderate (pain score < 3, stability of I-Th morphine) in 4 cases; and evaluated as failure (pain > 3, increase of I-Th morphine) in 3 cases. Clinical data...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
